General Structure Information 2bka HTATIP2 cc3(tip30)crystal strucure 1.7Å AUTH K.EL OMARI,L.E.BIRD,C.E.NICHOLS,J.REN,D.K.STAMMERSTITL CRYSTAL STRUCTURE OF CC3 (TIP30): IMPLICATIONS FORTITL 2 ITS ROLE AS A TUMOR SUPPRESSORREF J.BIOL.CHEM. V. 280 18229 2005REFN ISSN 0021-9258PMID 15728189DOI 10.1074/JBC.M501113200 Variant Set Distributions Mapped Variants
General Structure Information 2dyb NCF4 the crystal structure of human p40(phox) 3.15Å AUTH K.HONBOU,R.MINAKAMI,S.YUZAWA,R.TAKEYA,N.N.SUZUKI,AUTH 2 S.KAMAKURA,H.SUMIMOTO,F.INAGAKITITL FULL-LENGTH P40PHOX STRUCTURE SUGGESTS A BASIS FORTITL 2 REGULATION MECHANISM OF ITS MEMBRANE BINDING.REF EMBO J. V. 26 1176 2007REFN ISSN 0261-4189PMID 17290225DOI 10.1038/SJ.EMBOJ.7601561 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants
General Structure Information 3caq AKR1D1 crystal structure of 5beta-reductase (akr1d1) in complex with nadph 2.2Å AUTH F.FAUCHER,L.CANTIN,V.LUU-THE,F.LABRIE,R.BRETONTITL CRYSTAL STRUCTURES OF HUMAN DELTA4-3-KETOSTEROIDTITL 2 5BETA-REDUCTASE (AKR1D1) REVEAL THE PRESENCE OF ANTITL 3 ALTERNATIVE BINDING SITE RESPONSIBLE FOR SUBSTRATETITL 4 INHIBITION (DAGGER) (,) (DOUBLE DAGGER).REF BIOCHEMISTRY V. 47 13537 2008REFN ISSN 0006-2960PMID 19075558DOI 10.1021/BI801276H Variant Set Distributions […]
General Structure Information 2jkv PGD structure of human phosphogluconate dehydrogenase in complex with nadph at 2.53a 2.53Å AUTH S.S.NG,F.VON DELFT,E.S.PILKA,K.L.KAVANAGH,M.A.MCDONOUGH,AUTH 2 P.SAVITSKY,C.H.ARROWSMITH,J.WEIGELT,A.EDWARDS,M.SUNDSTROM,AUTH 3 C.J.SCHOFIELD,U.OPPERMANNTITL STRUCTURE OF HUMAN PHOSPHOGLUCONATE DEHYDROGENASE INTITL 2 COMPLEX WITH NADPH AT 2.53AREF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants
General Structure Information 3qfc POR crystal structure of human nadph-cytochrome p450 (v492e mutant) 1.8Å AUTH C.XIA,S.P.PANDA,C.C.MAROHNIC,P.MARTASEK,B.S.MASTERS,J.J.KIMTITL STRUCTURAL BASIS FOR HUMAN NADPH-CYTOCHROME P450TITL 2 OXIDOREDUCTASE DEFICIENCY.REF PROC.NATL.ACAD.SCI.USA V. 108 13486 2011REFN ISSN 0027-8424PMID 21808038DOI 10.1073/PNAS.1106632108 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants
General Structure Information 1dgb CAT human erythrocyte catalase 2.2Å AUTH C.D.PUTNAM,A.S.ARVAI,Y.BOURNE,J.A.TAINERTITL ACTIVE AND INHIBITED HUMAN CATALASE STRUCTURES:TITL 2 LIGAND AND NADPH BINDING AND CATALYTIC MECHANISM.REF J.MOL.BIOL. V. 296 295 2000REFN ISSN 0022-2836PMID 10656833DOI 10.1006/JMBI.1999.3458 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants
General Structure Information 3ccz HMGCR thermodynamic and structure guided design of statin hmg-coa reductase inhibitors 1.7Å AUTH R.W.SARVER,E.BILLS,G.BOLTON,L.D.BRATTON,AUTH 2 N.L.CASPERS,J.B.DUNBAR,M.S.HARRIS,R.H.HUTCHINGS,AUTH 3 R.M.KENNEDY,S.D.LARSEN,A.PAVLOVSKY,J.A.PFEFFERKORN,AUTH 4 G.BAINBRIDGETITL THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OFTITL 2 STATIN BASED INHIBITORS OFTITL 3 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE.REF J.MED.CHEM. V. 51 3804 2008REFN ISSN 0022-2623PMID 18540668DOI 10.1021/JM7015057 Variant Set Distributions Mapped Variants